Literature DB >> 32942139

The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival.

Adalberto Miranda-Filho1, Freddie Bray2, Hadrien Charvat2, Swaminathan Rajaraman3, Isabelle Soerjomataram2.   

Abstract

PURPOSE: This study addresses the need for a global cancer patient-based standard population that adjusts for the expected age structure of different cancers, thus aiding the comparison of survival estimates worldwide.
METHODS: Counts of age-specific incidence for 36 cancer sites in 185 countries for the year 2018 were extracted from IARC's GLOBOCAN database of national estimates. We used a multinomial mixture regression to identify clusters of cancer sites with similar age-specific profiles.
RESULTS: An updated standard entitled the World Cancer Patient Population (WCPP) is presented, derived from the current estimated global numbers of cancer patients that comprises three sets of age-specific weights. Around two-thirds of cancer sites were described by a unique standard, representing the majority of epithelial cancers more often diagnosed at older age groups. The two other standards represent a number of non-epithelial cancer types, and cancers common at younger and older age groups, respectively.
CONCLUSION: The WCPP proposed here provides a contemporary and global means to estimate age-standardised survival for international benchmarking purposes.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Age-standardised survival; Cancer epidemiology; Net survival; Standards

Mesh:

Year:  2020        PMID: 32942139      PMCID: PMC7768180          DOI: 10.1016/j.canep.2020.101802

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  12 in total

1.  An overview of cancer survival in developing countries.

Authors:  R Sankaranarayanan; R J Black; R Swaminathan; D M Parkin
Journal:  IARC Sci Publ       Date:  1998

2.  The age-adjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954-1955 and their geographical correlation.

Authors:  M SEGI; S FUJISAKU; M KURIHARA; Y NARAI; K SASAJIMA
Journal:  Tohoku J Exp Med       Date:  1960-08-25       Impact factor: 1.848

Review 3.  Cancer registration: principles and methods. Analysis of survival.

Authors:  D M Parkin; T Hakulinen
Journal:  IARC Sci Publ       Date:  1991

4.  Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction.

Authors:  R Sankaranarayanan
Journal:  IARC Sci Publ       Date:  2011

5.  Examining the effect of initialization strategies on the performance of Gaussian mixture modeling.

Authors:  Emilie Shireman; Douglas Steinley; Michael J Brusco
Journal:  Behav Res Methods       Date:  2017-02

6.  Standard cancer patient population for age standardising survival ratios.

Authors:  Isabella Corazziari; Mike Quinn; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2004-10       Impact factor: 9.162

7.  An alternative approach to age adjustment of cancer survival rates.

Authors:  Hermann Brenner; Volker Arndt; Olaf Gefeller; Timo Hakulinen
Journal:  Eur J Cancer       Date:  2004-10       Impact factor: 9.162

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  10 in total

1.  Childhood Cancer Survival, 2006-2012 Cohorts of Mexican Institute of Social Security Beneficiaries at the Central-South Region of Mexico.

Authors:  Angélica Castro-Ríos; Silvia Martínez-Valverde
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

2.  Research on the Construction of Bispecific-Targeted Sustained-Release Drug-Delivery Microspheres and Their Function in Treatment of Hepatocellular Carcinoma.

Authors:  Zi Li Huang; Feng Li; Jun Tao Zhang; Xiang Jun Shi; Yong Hua Xu; Xiu Yan Huang
Journal:  ACS Omega       Date:  2022-06-13

3.  A targeted siRNA-loaded PDL1-exosome and functional evaluation against lung cancer.

Authors:  Xianbin Lin; Liangan Lin; Jingyang Wu; Wentan Jiang; Jiayun Wu; Jianshen Yang; Chun Chen
Journal:  Thorac Cancer       Date:  2022-05-11       Impact factor: 3.223

4.  Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.

Authors:  Yan Zhang; Lin Chen; Xuanting Ye; Zhixiong Wu; Zeyu Zhang; Biaofeng Sun; Hong Fu; Chuangang Fu; Xiaofei Liang; Hong Jiang
Journal:  J Nanobiotechnology       Date:  2021-05-10       Impact factor: 10.435

5.  Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.

Authors:  Jie Yan; Daihong Wan
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

6.  Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.

Authors:  Eudald Felip; Lucía Gutiérrez-Chamorro; Maica Gómez; Edurne Garcia-Vidal; Margarita Romeo; Teresa Morán; Laura Layos; Laia Pérez-Roca; Eva Riveira-Muñoz; Bonaventura Clotet; Pedro Luis Fernandez; Ricard Mesía; Anna Martínez-Cardús; Ester Ballana; Mireia Margelí
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

Review 7.  Effect of fasting on cancer: A narrative review of scientific evidence.

Authors:  Sagun Tiwari; Namrata Sapkota; Zhenxiang Han
Journal:  Cancer Sci       Date:  2022-08-10       Impact factor: 6.518

Review 8.  Emerging treatments for bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer.

Authors:  Hyung Suk Kim; Ho Kyung Seo
Journal:  Investig Clin Urol       Date:  2021-05-27

9.  Role and Mechanism of Exosome-Derived Long Noncoding RNA HOTAIR in Lung Cancer.

Authors:  Lanlan Chen; Shenhui Huang; Jincheng Huang; Qiujuan Chen; Qihong Zhuang
Journal:  ACS Omega       Date:  2021-06-29

10.  Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer.

Authors:  Laureline Lamy; Jacques Thomas; Agnès Leroux; Jean-François Bisson; Kari Myren; Aslak Godal; Gry Stensrud; Lina Bezdetnaya
Journal:  Biomedicines       Date:  2022-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.